Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Angiography with Amipaque

J T Lamb

    Neuroradiology
    |January 1, 1978
    PubMed
    Summary
    This summary is machine-generated.

    Amipaque (metrizamide) is a more comfortable and safer contrast agent than Urografin 310 M for angiography. It significantly reduced discomfort and eliminated neurological complications in spinal arteriography patients.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Bilateral sequential inferior petrosal sinus sampling with corticotrophin-releasing hormone stimulation in the diagnosis of Cushing's disease.

    European journal of endocrinology·1998
    Same author

    Shrinkage of thyrotrophin secreting pituitary adenoma treated with octreotide.

    Postgraduate medical journal·1991
    Same author

    Nose-blowing and CSF rhinorrhoea.

    Lancet (London, England)·1991
    Same author

    Thin section computed tomography in the evaluation of naso-ethmoidal trauma.

    Clinical radiology·1990
    Same author

    Diagnostic and counselling difficulties using a fully comprehensive screening protocol for families at risk for tuberous sclerosis.

    Journal of medical genetics·1989
    Same author

    Seizures after intravenous contrast media for cranial computed tomography.

    Journal of neurology, neurosurgery, and psychiatry·1989

    Area of Science:

    • Radiology
    • Neuroradiology
    • Vascular Imaging

    Background:

    • Contrast agents are essential for angiography.
    • Urografin 310 M has been used, but patient comfort and safety are concerns.
    • Amipaque (metrizamide) is a newer alternative.

    Purpose of the Study:

    • To compare the comfort and safety of Amipaque (metrizamide) versus Urografin 310 M.
    • To evaluate complication rates associated with each contrast agent.

    Main Methods:

    • A comparative study involving 42 patients undergoing selective or subselective external carotid, subclavian, and spinal angiography.
    • Direct comparison of patient-reported discomfort and observed neurological complications.

    Main Results:

    Related Experiment Videos

    • Amipaque (metrizamide) was considerably less uncomfortable than Urografin 310 M.
    • Two of five patients experienced transient neurological complications with Urografin 310 M during spinal arteriography.
    • No complications were observed with Amipaque (metrizamide) in repeat examinations.

    Conclusions:

    • Amipaque (metrizamide) offers improved patient comfort compared to Urografin 310 M.
    • Amipaque (metrizamide) demonstrates a superior safety profile, particularly in reducing neurological complications during spinal angiography.